Differentiation of Human Cardiac Atrial Appendage Stem Cells into Adult Cardiomyocytes: A Role for the Wnt Pathway?


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
30 May 2020
Historique:
received: 29 04 2020
revised: 26 05 2020
accepted: 28 05 2020
entrez: 4 6 2020
pubmed: 4 6 2020
medline: 1 4 2021
Statut: epublish

Résumé

Human cardiac stem cells isolated from atrial appendages based on aldehyde dehydrogenase activity (CASCs) can be expanded in vitro and differentiate into mature cardiomyocytes. In this study, we assess whether Wnt activation stimulates human CASC proliferation, whereas Wnt inhibition induces cardiac maturation. CASCs were cultured as described before. Conventional PCR confirmed the presence of the Frizzled receptors. Small-molecule inhibitors (IWP2, C59, XAV939, and IWR1-endo) and activator (CHIR99021) of the Wnt/β -catenin signaling pathway were applied, and the effect on β-catenin and target genes for proliferation and differentiation was assessed by Western blot and RT-qPCR. CASCs express multiple early cardiac differentiation markers and are committed toward myocardial differentiation. They express several Frizzled receptors, suggesting a role for Wnt signaling in clonogenicity, proliferation, and differentiation. Wnt activation increases total and active β-catenin levels. However, this does not affect CASC proliferation or clonogenicity. Wnt inhibition upregulated early cardiac markers but could not induce mature myocardial differentiation. When CASCs are committed toward myocardial differentiation, the Wnt pathway is active and can be modulated. However, despite its role in cardiogenesis and myocardial differentiation of pluripotent stem-cell populations, our data indicate that Wnt signaling has limited effects on CASC clonogenicity, proliferation, and differentiation.

Identifiants

pubmed: 32486259
pii: ijms21113931
doi: 10.3390/ijms21113931
pmc: PMC7312541
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Flemish Agency for Innovation by Science and Technology
ID : IWT 121560

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Circ Res. 2015 Apr 10;116(8):1346-60
pubmed: 25700037
Genes Dev. 2005 Feb 1;19(3):387-96
pubmed: 15687261
Cardiol J. 2009;16(6):493-9
pubmed: 19950084
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19762-7
pubmed: 19073933
Cell Prolif. 2015 Apr;48(2):175-86
pubmed: 25630660
J Mol Cell Cardiol. 2016 Aug;97:235-44
pubmed: 27291064
Nat Protoc. 2013 Jan;8(1):162-75
pubmed: 23257984
Nat Commun. 2015 Oct 30;6:8701
pubmed: 26515110
Cell Res. 2005 Jan;15(1):28-32
pubmed: 15686623
Biomed Res Int. 2013;2013:503047
pubmed: 23484127
Cell. 2003 Sep 19;114(6):763-76
pubmed: 14505575
Lancet. 2019 Mar 16;393(10176):1084
pubmed: 30894259
Nature. 2014 May 15;509(7500):337-41
pubmed: 24805242
Cell Mol Life Sci. 2011 Jun;68(12):2141-56
pubmed: 20972814
Cell Stem Cell. 2007 Aug 16;1(2):165-79
pubmed: 18371348
Int J Cardiol. 2015 Dec 15;201:10-9
pubmed: 26285182
Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14068-73
pubmed: 17709737
Development. 2016 Apr 15;143(8):1242-58
pubmed: 27095490
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Biomed Res Int. 2014;2014:679168
pubmed: 24864252
Lancet. 2011 Nov 26;378(9806):1847-57
pubmed: 22088800
Circ Res. 2013 Aug 2;113(4):399-407
pubmed: 23743334
BMC Res Notes. 2014 Apr 29;7:273
pubmed: 24779365
Cell. 2006 Dec 15;127(6):1137-50
pubmed: 17123591
Circ Res. 2011 Dec 9;109(12):1363-74
pubmed: 22034491
Nature. 2008 Jul 3;454(7200):104-8
pubmed: 18480752
Development. 2003 Dec;130(24):5953-64
pubmed: 14573514
Circ Res. 2001 Dec 7;89(12):1122-9
pubmed: 11739276
Nat Methods. 2014 Aug;11(8):855-60
pubmed: 24930130
Cardiovasc Res. 2013 Mar 1;97(3):413-23
pubmed: 23257022
Nat Rev Mol Cell Biol. 2012 Dec;13(12):767-79
pubmed: 23151663
Circ Res. 2010 Jul 23;107(2):186-99
pubmed: 20651295
J Cardiovasc Transl Res. 2016 Dec;9(5-6):405-418
pubmed: 27542008
Cell Regen (Lond). 2015 Jul 08;4(1):3
pubmed: 26157574
J Biol Chem. 2006 Jun 30;281(26):17751-7
pubmed: 16798748
Development. 2008 Oct;135(19):3185-90
pubmed: 18715946

Auteurs

Leen Willems (L)

UHasselt, Faculty of Medicine and Life Sciences, Martelarenlaan 42, 3500 Hasselt, Belgium.
Laboratory of Experimental Hematology, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium.

Annick Daniëls (A)

Laboratory of Experimental Hematology, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium.

Yanick Fanton (Y)

UHasselt, Faculty of Medicine and Life Sciences, Martelarenlaan 42, 3500 Hasselt, Belgium.
Laboratory of Experimental Hematology, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium.

Loes Linsen (L)

UHasselt, Faculty of Medicine and Life Sciences, Martelarenlaan 42, 3500 Hasselt, Belgium.
Laboratory of Experimental Hematology, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium.
University Biobank Limburg, Jessa Hospital, 3500 Hasselt, Belgium.

Lize Evens (L)

UHasselt, Faculty of Medicine and Life Sciences, Martelarenlaan 42, 3500 Hasselt, Belgium.

Virginie Bito (V)

UHasselt, Faculty of Medicine and Life Sciences, Martelarenlaan 42, 3500 Hasselt, Belgium.

Jeroen Declercq (J)

UHasselt, Faculty of Medicine and Life Sciences, Martelarenlaan 42, 3500 Hasselt, Belgium.
Laboratory of Experimental Hematology, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium.

Jean-Luc Rummens (JL)

UHasselt, Faculty of Medicine and Life Sciences, Martelarenlaan 42, 3500 Hasselt, Belgium.
Laboratory of Experimental Hematology, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium.
University Biobank Limburg, Jessa Hospital, 3500 Hasselt, Belgium.

Karen Hensen (K)

UHasselt, Faculty of Medicine and Life Sciences, Martelarenlaan 42, 3500 Hasselt, Belgium.
Laboratory of Experimental Hematology, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium.

Marc Hendrikx (M)

UHasselt, Faculty of Medicine and Life Sciences, Martelarenlaan 42, 3500 Hasselt, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH